Recent Biotech, Cannabis, Food & Drug, & Pharma Administration News

Publication Date Organization
Apr
6
2020
 CARES Act Prompts Changes to Employer-Sponsored Health Plans Ogletree, Deakins, Nash, Smoak & Stewart, P.C.
Apr
6
2020
 U.S. Department of Justice Issues First COVID-19-Related Business Review Letter to Medical Supplies Distributors Mintz
Apr
6
2020
 CMS “Hospitals Without Walls” Waiver: Looking To ASCs to Provide Relief Sheppard, Mullin, Richter & Hampton LLP
Apr
6
2020
 Push Back on Plastic Bag Bans Keller and Heckman LLP
Apr
6
2020
 Novel Virus Brings Novel Coverage Theories ArentFox Schiff LLP
Apr
6
2020
 COVID-19 Liability Immunity - What You Need to Know Now Womble Bond Dickinson (US) LLP
Apr
6
2020
 EPA Takes Action to Ease the Production of Disinfectants Approved for Use Against the Novel Coronavirus Beveridge & Diamond PC
Apr
6
2020
 FDA Policy Provides Enforcement Relief Regarding Certain Medical Devices Due to Pandemic Beveridge & Diamond PC
Apr
6
2020
 EPA Highlights Enforcement Against Disinfectant Products Making Fraudulent Coronavirus Claims Beveridge & Diamond PC
Apr
6
2020
 FDA Resumes Records Review Under the FSVP Rule by Remote Inspections Instead of Onsite Visits to Importers Keller and Heckman LLP
Apr
3
2020
 COVID-19: Notable Impacts for Post-Acute Providers from the CARES Act, CMS Blanket Waivers, and the CMS Interim Final Rule
Apr
3
2020
 Commercial Payors and Medicaid Telehealth Billing Womble Bond Dickinson (US) LLP
Apr
3
2020
 FDA Funding Opportunity Announcement: “Exploring the use of Real-World Data to Generate Real-World Evidence in Regulatory Decision-Making (U01) Clinical Trials Optional” Faegre Drinker
Apr
3
2020
 Legal Liability of Healthcare Providers for Care Provided During COVID-19 Pandemic Epstein Becker & Green, P.C.
Apr
3
2020
 Russian Federation Accepting Nominations to New Chemical Inventory Bergeson & Campbell, P.C.
Apr
2
2020
 CMS Issues Temporary Waivers in Broad Coronavirus Response Sheppard, Mullin, Richter & Hampton LLP
Apr
2
2020
 Class Action Ascertainability in the Eleventh Circuit: What Makes the Cut? Bilzin Sumberg
Apr
2
2020
 Doctor Fraud: False Claims and Controlled Substances an Ongoing Problem for the Medical Industry Stark & Stark
Apr
2
2020
 Strategies for Collaborating With Other Health Care Firms to Expand Production and Secure the Supply Chain Jones Walker LLP
Apr
2
2020
 FDA Provides Temporary Flexibility to Chain Restaurants and Similar Retail Food Establishments in Response to COVID-19 Keller and Heckman LLP
Apr
1
2020
 Court Of Chancery Orders Specific Performance Of Merger Agreement, Finding That Fraud Contained In FDA Filings For Approval Of Target Product Did Not Rise To A “Material Adverse Effect” K&L Gates LLP
Apr
1
2020
 Gifting Goods & Services to the U.S. Government in the Wake of the Coronavirus Outbreak Sheppard, Mullin, Richter & Hampton LLP
Apr
1
2020
 TTB Steps Up Amid Crisis - Postpones Excise Tax Filing and Payment Dates Norris McLaughlin P.A.
Apr
1
2020
 Federal Judge Finds Claims Too Speculative and Dismisses “Natural” Peanut Butter Class Action Keller and Heckman LLP
Apr
1
2020
 Detailed Summary of Federal Requirements for Production of Hand Sanitizing Products McDermott Will & Schulte LLP
Apr
1
2020
 Beverage Mislabeling Suit Runs Out of Juice Proskauer Rose LLP
Mar
31
2020
 FDA Issues Guidance on Regulatory Submissions in Alternate Electronic Format, Including Type III DMFs Keller and Heckman LLP
Mar
31
2020
 TSCA Fees Rule Update – EPA Issues No Action Assurance Memorandum Beveridge & Diamond PC
Displaying 5741 - 5768 of 12600
Subscribe to The 10 Latest Biological, Life Sciences, and Cleantech Law Articles
 
NLR Logo
We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters.

 

Sign Up for any (or all) of our 25+ Newsletters